Published by Benjamin Chiou on 14th April 2026
(Sharecast News) - AIM-listed biotech Physiomics has announced a new contract with client Numab Therapeutics to help development activities for the latter's oncology pipeline.
URL: http://www.digitallook.com/dl/news/story/35850079/...